Respiratory Measurement of Volume Change Using Accelerometer, Thermographic Camera Electrical Impedance Tomography and Motion Correlation Analysis Using Mattress Sensor in Healthy Individuals

NCT ID: NCT04964245

Last Updated: 2021-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-31

Study Completion Date

2021-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tidal volume can be the most important technical indicator for ventilation. Measuring the volume of breathing can be used as an indicator of how effective a patient's gas exchange is, and as a predictive indicator of the statue of respiratory disease indirectly. These Tidal volumes can be measured using spirometry and pneumotachograph, and the breathing volume and the rate of airflow can directly or indirectly evaluate the lung function of the patient.

However, spirometry has limitations that patients who are difficult to measure, and that it is difficult to measure in bed. In this work, the movement of the thorax due to breathing is measured in a non-invasive manner (accelerometer, thermographic camera) and the accuracy is compared through changes in thoracic impedance obtained through Pulmovista 500. Furthermore, we would like to correlate the motion of the measured object through a mattress sensor.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Adult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Respiration monitoring group

The respiration is simultaneously measured by accelerometer, thermographic camera, Impedance Tomography, and mattress sensor.

Group Type EXPERIMENTAL

accelometer

Intervention Type DEVICE

the respiration parameters are measured using an accelometer.

thermographic camera

Intervention Type DEVICE

the respiration parameters are measured using an thermographic camera.

Electrical Impedance Tomography

Intervention Type DEVICE

the respiration parameters are measured using an electrical impedance tomograhy.

Mattress Sensor

Intervention Type DEVICE

the respiration parameters are measured using an Mattress pressure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

accelometer

the respiration parameters are measured using an accelometer.

Intervention Type DEVICE

thermographic camera

the respiration parameters are measured using an thermographic camera.

Intervention Type DEVICE

Electrical Impedance Tomography

the respiration parameters are measured using an electrical impedance tomograhy.

Intervention Type DEVICE

Mattress Sensor

the respiration parameters are measured using an Mattress pressure

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

FLIR 655sc

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. over 19, under 50 years old and common BMI
2. non-smoking, person without cardiopulmonary disease.

Exclusion Criteria

1\. smoking, cardiopulmonary, infectious diseases.
Minimum Eligible Age

19 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeongmin Kim

Role: PRINCIPAL_INVESTIGATOR

Severance Hospital, Yonsei University Health System

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Severance Hospital, Yonsei University Health System

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jeongmin Kim

Role: CONTACT

+82 10-8926-2684

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jeongmin Kim

Role: primary

+82 10-8926-2684

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4-2020-1320

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.